Quinton (Ding Quan) Ng, PhD, BSc (Hon)
he/him/his
Postdoctoral AssociateDownloadHi-Res Photo
Cards
Education
PhD
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
BSc (Hon)
National University of Singapore, Pharmacy (2019)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 48 Publications
- 365 Citations
- 12 Yale Co-Authors
Featured Publication
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
Education
PhD
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
BSc (Hon)
National University of Singapore, Pharmacy (2019)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 48 Publications
- 365 Citations
- 12 Yale Co-Authors
Featured Publication
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
Education
PhD
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
BSc (Hon)
National University of Singapore, Pharmacy (2019)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 48 Publications
- 365 Citations
- 12 Yale Co-Authors
Featured Publication
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
About
Copy Link
Titles
Postdoctoral Associate
Biography
Quinton Ng, PhD, BScPharm(Hons), is a postdoctoral researcher on the Yale Cancer Center Decision Science Team and Goshua Lab. A pharmacist by training and a pharmacoepidemiologist, he focuses on health outcomes research with a deep commitment to ensuring equitable care across the cancer care continuum. His passion for this work is profoundly personal, stemming from his experience as a caregiver.
His doctoral research at the University of California, Irvine, which earned him the PhRMA Foundation Predoctoral Fellowship, established a novel framework for incorporating integrative oncology therapies into cancer survivorship from an evidence-, science-, and value-based perspective.
At Yale, he continues his research by developing expertise at the intersection of pharmacoepidemiology and decision science. His current work focuses on quantifying the value of new therapies and underutilized interventions in clinical oncology and hematology to inform evidence-based practice, improve patient outcomes, enhance healthcare decision making, and optimize healthcare resource allocation.
Last Updated on February 27, 2026.
Education & Training
- PhD
- University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
- BSc (Hon)
- National University of Singapore, Pharmacy (2019)
Research
Copy Link
Overview
Medical Research Interests
Administrative Claims, Healthcare; Biomarkers; Biostatistics; Cancer Survivors; Clinical Trial; Comparative Effectiveness Research; Cost-Effectiveness Analysis; Drug-Related Side Effects and Adverse Reactions; Economics, Medical; Electronic Health Records; Evidence-Based Medicine; Health Equity; Integrative Oncology; Medical Oncology; Pharmacoepidemiology; Survivorship
ORCID
0000-0002-0754-7901- View Lab Website
Goshua Lab
Research at a Glance
Yale Co-Authors
Frequent collaborators of Quinton (Ding Quan) Ng's published research.
Publications Timeline
A big-picture view of Quinton (Ding Quan) Ng's research output by year.
Research Interests
Research topics Quinton (Ding Quan) Ng is interested in exploring.
Manraj Singh Sra, MBBS
Satoko Ito, MD, PhD
George Goshua, MD, SM, FACP
Alfred Lee, MD, PhD
Amer Zeidan, MBBS, MD
Jan Philipp Bewersdorf, MD, FACP
48Publications
365Citations
Cancer Survivors
Biomarkers
Survivorship
Electronic Health Records
Integrative Oncology
Publications
Featured Publications
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
Ng DQ, Heshmatipour M, Trudeau J, Sridhar A, Pluimer B, Drayson OGG, Lavasani SM, Parajuli R, Lee S, Agrawal A, Acharya MM, Limoli CL, Harris RE, Xie L, Malik S, Chan A. Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial. J Natl Cancer Inst 2026 PMID: 41926740, DOI: 10.1093/jnci/djag096.Peer-Reviewed Original ResearchReal-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain
Ng D, Lee S, Lee R, Wang Y, Chan A. Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain. BMC Medicine 2024, 22: 394. PMID: 39285302, PMCID: PMC11406884, DOI: 10.1186/s12916-024-03626-2.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBreast cancer survivorsImpact of acupunctureCancer survivorsHealthcare resource utilizationHealthcare costsAcupuncture-treated patientsHigh-utilizing patientsTotal healthcare costsShort-term opioidsCommercial health insuranceAcupuncture utilizationAcupuncture-treatedPost-acupunctureAcupuncture effectsPrevalence of opioidsMusculoskeletal painAcupunctureCancer diagnosisHealth insuranceReal-world settingsNSAID usePrescription fillsHealthcareUnited StatesResource utilizationDynamin-1 is a potential mediator in cancer-related cognitive impairment
Ng D, Hudson C, Nguyen T, Gupta S, Koh Y, Acharya M, Chan A. Dynamin-1 is a potential mediator in cancer-related cognitive impairment. Neurotherapeutics 2024, 22: e00480. PMID: 39516074, PMCID: PMC11742811, DOI: 10.1016/j.neurot.2024.e00480.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCancer-related cognitive impairmentFemale mouse modelNon-cancer controlsSpatial recognition memoryConsequences of cancer treatmentYoung adult cancerCytotoxic treatmentControl miceHippocampal CA1Cancer patientsMouse modelSynaptic activityAdult cancersCA3 subregionNeurological consequencesAnimal modelsCognitive impairmentAnimal studiesHuman studiesCancer treatmentNon-cancer participantsTherapeutic targetCancerExposure to cancerChemotherapySubstance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort
Ng D, Ritt-Olson A, Freyer D, Miller K, Thomas S, Milam J, Chan A. Substance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort. JCO Oncology Practice 2022, 19: e345-e354. PMID: 36508698, PMCID: PMC10022886, DOI: 10.1200/op.22.00458.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsYoung adult childhood cancer survivorsCancer-related cognitive impairmentYoung adult survivors of childhood cancerCancer-related late effectsAdult survivors of childhood cancerAdult childhood cancer survivorsLong-term follow-up clinicSurvivors of childhood cancerChildhood cancer survivorsSubstance use behaviorsYoung adult survivorsLog-binomial regressionMental health issuesSubstance useCognitive impairmentFollow-up clinicLong-term healthAssociated with reportsCancer survivorsUse behaviorsPsychological distressChildhood cancerDepressive symptomsCovariate adjustmentHealth issuesCurrent and recommended practices for evaluating adverse drug events using electronic health records: A systematic review
Ng D, Dang E, Chen L, Nguyen M, Nguyen M, Samman S, Nguyen T, Cadiz C, Nguyen L, Chan A. Current and recommended practices for evaluating adverse drug events using electronic health records: A systematic review. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2021, 4: 1457-1468. DOI: 10.1002/jac5.1524.Peer-Reviewed Original ResearchCitationsAltmetricConceptsElectronic health recordsAdverse drug eventsNewcastle-Ottawa ScaleHealth recordsDrug eventsSystematic reviewAbstract Electronic health recordsModified Newcastle-Ottawa ScaleEvaluate adverse drug eventsStructured EHR dataPeer-reviewed journalsMedian NOS scorePrescribing recordsRecommended practicesEHR dataMethodological qualityIntention-to-treatThematic analysisEffect modifiersDiagnosis codesData synthesisPharmacoepidemiologic researchCohort studyEnd-to-endNOS score
2026
Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds
Wang D, Sra M, Ng D, Tadepalli A, Rinaldi K, Ito S, Cuker A, Goshua G. Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds. Blood Advances 2026 PMID: 42206692, DOI: 10.1182/bloodadvances.2026020143.Peer-Reviewed Original ResearchCost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia
Ito S, Potnis K, Ng D, Patel K, Sra M, Shallis R, Podoltsev N, Kewan T, Stempel J, Mendez L, Huntington S, Stahl M, Zeidan A, Bewersdorf J, Goshua G. Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia. Blood Red Cells & Iron 2026, 2: 100076. PMID: 42077391, PMCID: PMC13134686, DOI: 10.1016/j.brci.2026.100076.Peer-Reviewed Original ResearchThis study investigates how trainee-led teams developed updated consensus guidelines for managing peritoneal surface malignancies, demonstrating effective collaboration models for complex medical evidence synthesis.Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding
Wang D, Sra M, Ito S, Ng D, Glaeser-Khan S, Wang D, Hirniak S, Lee A, Cuker A, Goshua G. Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding. Blood Advances 2026, 10: 1508-1517. PMID: 41504430, PMCID: PMC12952766, DOI: 10.1182/bloodadvances.2025018315.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHeavy menstrual bleedingIV iron dextranIron deficiency anemiaQuality-adjusted life yearsOral ferrous sulfateFirst-line treatmentIron dextranOral ironMenstrual bleedingCost-effective treatmentIron deficiencyFrequent gastrointestinal side effectsIV iron sucroseOral iron therapyFirst-line therapyQuality-adjusted life-year benefitsFirst-line optionIncremental cost-effectiveness ratioGastrointestinal side effectsCohort of womenCost-effectiveness ratioIron therapyIron sucroseIV ironTreatment delayHealth care utilization and self-reported health status among US cancer survivors by rurality and area deprivation
Lee H, Lee D, Ng D, Wiese D, Singh G, Jemal A, Islami F. Health care utilization and self-reported health status among US cancer survivors by rurality and area deprivation. Med 2026, 101030. PMID: 41720101, DOI: 10.1016/j.medj.2026.101030.Peer-Reviewed Original ResearchAltmetricConceptsSelf-reported health statusAssociation of ruralityCancer survivorsHealth care providersHealth care utilizationArea deprivationHealth statusCare providersCare utilizationProfessional visitsHealth care professional visitsOdds ratioUS cancer survivorsHealth professional visitsPoor health statusMultiple sociodemographic characteristicsPoor physical healthPrimary care physiciansMental health professionalsLogistic regression modelsDeprived areasHealth professionalsCare physiciansDeprived neighbourhoodsPoor healthThe association between loneliness and quality of life in cancer survivors: All of Us research program
Lee H, Ng D, Lee D, Baeker Bispo J, Jemal A, Islami F. The association between loneliness and quality of life in cancer survivors: All of Us research program. Quality Of Life Research 2026, 35: 44. PMID: 41533225, DOI: 10.1007/s11136-025-04159-8.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsCancer survivorsQuality of lifeHealth outcomesMental healthSociodemographic characteristicsSevere fatigueFair/poor mental healthMultiple health behaviorsUs Research ProgramOverall quality of lifeOverall qualityMagnitude of associationCross-sectional analysisHealth effectsLifestyle behaviorsOlder survivorsHealth behaviorsSociodemographic factorsEffects of lonelinessPhysical healthYoung survivorsAdverse associationGeneral populationProgram dataHealth
Academic Achievements & Community Involvement
Copy Link
Honors
honor Predoctoral Fellowship in Value Assessment and Health Outcomes Research
04/13/2023National AwardPhRMA FoundationDetailsUnited States
Links
Copy Link
Get In Touch
Copy Link
Contacts
Email
Locations
Yale Cancer Center Decision Science
Academic Office
300 George Street, Ste 900
New Haven, CT 06511
Social Media